Selected research
Industry Research
Sanger Sequencers Industry Research Report 2026
Market perspective
The global Sanger Sequencers market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Sanger Sequencers is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Sanger Sequencers is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Sanger Sequencers is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Sanger Sequencers include Danaher, Promega, Denogen (Beijing) Bio-Sci&Tech, Ningbo HEALTH Gene Technologies, Thermo Fisher Scientific and Superyears Gene, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Sanger Sequencers market in terms of revenue (US$ million) and, where applicable, sales volume (Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Sanger Sequencers Market by Company
Danaher
Promega
Denogen (Beijing) Bio-Sci&Tech
Ningbo HEALTH Gene Technologies
Thermo Fisher Scientific
Superyears Gene
Sanger Sequencers Segment by Type
4-Channel
8-Channel
Others
Sanger Sequencers Segment by Application
Clinical Testing
Scientific Research
Sanger Sequencers Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sanger Sequencers market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sanger Sequencers and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sanger Sequencers.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Sanger Sequencers manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Sanger Sequencers by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Sanger Sequencers in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 4-Channel
- 8-Channel
- Others
Applications
- Clinical Testing
- Scientific Research
Companies covered
- Danaher
- Promega
- Denogen (Beijing) Bio-Sci&Tech
- Ningbo HEALTH Gene Technologies
- Thermo Fisher Scientific
- Superyears Gene
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Sanger Sequencers Market Size (2021-2032)
- 2.2.2 Global Sanger Sequencers Sales (2021-2032)
- 2.2.3 Global Sanger Sequencers Market Average Price (2021-2032)
- 2.3 Sanger Sequencers by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 4-Channel
- 2.3.3 8-Channel
- 2.3.4 Others
- 2.4 Sanger Sequencers by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Clinical Testing
- 2.4.3 Scientific Research
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Sanger Sequencers Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Sanger Sequencers Sales (Units) of Manufacturers (2021-2026)
- 3.3 Global Sanger Sequencers Revenue of Manufacturers (2021-2026)
- 3.4 Global Sanger Sequencers Average Price by Manufacturers (2021-2026)
- 3.5 Global Sanger Sequencers Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Sanger Sequencers, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Sanger Sequencers, Product Type & Application
- 3.8 Global Manufacturers of Sanger Sequencers, Established Date
- 3.9 Global Sanger Sequencers Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Danaher
- 4.1.1 Danaher Company Information
- 4.1.2 Danaher Business Overview
- 4.1.3 Danaher Sanger Sequencers Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Danaher Sanger Sequencers Product Portfolio
- 4.1.5 Danaher Recent Developments
- 4.2 Promega
- 4.2.1 Promega Company Information
- 4.2.2 Promega Business Overview
- 4.2.3 Promega Sanger Sequencers Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Promega Sanger Sequencers Product Portfolio
- 4.2.5 Promega Recent Developments
- 4.3 Denogen (Beijing) Bio-Sci&Tech
- 4.3.1 Denogen (Beijing) Bio-Sci&Tech Company Information
- 4.3.2 Denogen (Beijing) Bio-Sci&Tech Business Overview
- 4.3.3 Denogen (Beijing) Bio-Sci&Tech Sanger Sequencers Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Denogen (Beijing) Bio-Sci&Tech Sanger Sequencers Product Portfolio
- 4.3.5 Denogen (Beijing) Bio-Sci&Tech Recent Developments
- 4.4 Ningbo HEALTH Gene Technologies
- 4.4.1 Ningbo HEALTH Gene Technologies Company Information
- 4.4.2 Ningbo HEALTH Gene Technologies Business Overview
- 4.4.3 Ningbo HEALTH Gene Technologies Sanger Sequencers Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Ningbo HEALTH Gene Technologies Sanger Sequencers Product Portfolio
- 4.4.5 Ningbo HEALTH Gene Technologies Recent Developments
- 4.5 Thermo Fisher Scientific
- 4.5.1 Thermo Fisher Scientific Company Information
- 4.5.2 Thermo Fisher Scientific Business Overview
- 4.5.3 Thermo Fisher Scientific Sanger Sequencers Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Thermo Fisher Scientific Sanger Sequencers Product Portfolio
- 4.5.5 Thermo Fisher Scientific Recent Developments
- 4.6 Superyears Gene
- 4.6.1 Superyears Gene Company Information
- 4.6.2 Superyears Gene Business Overview
- 4.6.3 Superyears Gene Sanger Sequencers Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Superyears Gene Sanger Sequencers Product Portfolio
- 4.6.5 Superyears Gene Recent Developments
5 Global Sanger Sequencers Market Scenario by Region
- 5.1 Global Sanger Sequencers Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Sanger Sequencers Sales by Region: 2021-2032
- 5.2.1 Global Sanger Sequencers Sales by Region: 2021-2026
- 5.2.2 Global Sanger Sequencers Sales by Region: 2027-2032
- 5.3 Global Sanger Sequencers Revenue by Region: 2021-2032
- 5.3.1 Global Sanger Sequencers Revenue by Region: 2021-2026
- 5.3.2 Global Sanger Sequencers Revenue by Region: 2027-2032
- 5.4 North America Sanger Sequencers Market Facts & Figures by Country
- 5.4.1 North America Sanger Sequencers Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Sanger Sequencers Sales by Country (2021-2032)
- 5.4.3 North America Sanger Sequencers Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Sanger Sequencers Market Facts & Figures by Country
- 5.5.1 Europe Sanger Sequencers Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Sanger Sequencers Sales by Country (2021-2032)
- 5.5.3 Europe Sanger Sequencers Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Sanger Sequencers Market Facts & Figures by Country
- 5.6.1 Asia Pacific Sanger Sequencers Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Sanger Sequencers Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Sanger Sequencers Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Sanger Sequencers Market Facts & Figures by Country
- 5.7.1 South America Sanger Sequencers Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Sanger Sequencers Sales by Country (2021-2032)
- 5.7.3 South America Sanger Sequencers Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Sanger Sequencers Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Sanger Sequencers Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Sanger Sequencers Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Sanger Sequencers Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Sanger Sequencers Sales by Type (2021-2032)
- 6.1.1 Global Sanger Sequencers Sales by Type (2021-2032) & (Units)
- 6.1.2 Global Sanger Sequencers Sales Market Share by Type (2021-2032)
- 6.2 Global Sanger Sequencers Revenue by Type (2021-2032)
- 6.2.1 Global Sanger Sequencers Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Sanger Sequencers Revenue Market Share by Type (2021-2032)
- 6.3 Global Sanger Sequencers Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Sanger Sequencers Sales by Application (2021-2032)
- 7.1.1 Global Sanger Sequencers Sales by Application (2021-2032) & (Units)
- 7.1.2 Global Sanger Sequencers Sales Market Share by Application (2021-2032)
- 7.2 Global Sanger Sequencers Revenue by Application (2021-2032)
- 7.2.1 Global Sanger Sequencers Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Sanger Sequencers Revenue Market Share by Application (2021-2032)
- 7.3 Global Sanger Sequencers Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Sanger Sequencers Value Chain Analysis
- 8.1.1 Sanger Sequencers Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Sanger Sequencers Production Mode & Process
- 8.2 Sanger Sequencers Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Sanger Sequencers Distributors
- 8.2.3 Sanger Sequencers Customers
9 Global Sanger Sequencers Analyzing Market Dynamics
- 9.1 Sanger Sequencers Industry Trends
- 9.2 Sanger Sequencers Industry Drivers
- 9.3 Sanger Sequencers Industry Opportunities and Challenges
- 9.4 Sanger Sequencers Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst